These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma. Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941 [TBL] [Abstract][Full Text] [Related]
3. Retinal vascular precipitates during administration of melphalan into the ophthalmic artery. Superstein R; Lederer D; Dubois J; Hamel P; Carret AS; Callejo S JAMA Ophthalmol; 2013 Jul; 131(7):963-5. PubMed ID: 23846208 [No Abstract] [Full Text] [Related]
4. Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma. Tse BC; Kaste SC; Brennan R; Orr B; Wilson MW Ophthalmology; 2015 Feb; 122(2):435-7. PubMed ID: 25439599 [No Abstract] [Full Text] [Related]
5. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach. Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742 [TBL] [Abstract][Full Text] [Related]
6. Delayed Cerebral Infarction Following Intra-arterial Chemotherapy for Retinoblastoma. De la Huerta I; Seider MI; Hetts SW; Damato BE JAMA Ophthalmol; 2016 Jun; 134(6):712-4. PubMed ID: 27077487 [No Abstract] [Full Text] [Related]
7. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434 [TBL] [Abstract][Full Text] [Related]
9. Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience. Michaels ST; Abruzzo TA; Augsburger JJ; Corrêa ZM; Lane A; Geller JI J Pediatr Hematol Oncol; 2016 Jan; 38(1):65-9. PubMed ID: 26583615 [TBL] [Abstract][Full Text] [Related]
10. Changes in Retinal Thickness on OCT from Intravitreal Melphalan. Narala R; Kim JW; Lang P; Le BHA; Hendargo HC; Branco D; Berry JL Ophthalmol Retina; 2019 Mar; 3(3):288-289. PubMed ID: 31014710 [No Abstract] [Full Text] [Related]
11. Ocular dysmotility after intra-arterial chemotherapy for retinoblastoma. Lambert NG; Winegar BA; Feola GP; Ramasubramanian A J AAPOS; 2015 Dec; 19(6):574-7. PubMed ID: 26691048 [TBL] [Abstract][Full Text] [Related]
12. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review. Ong SJ; Chao AN; Wong HF; Liou KL; Kao LY Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196 [TBL] [Abstract][Full Text] [Related]
13. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Suzuki S; Yamane T; Mohri M; Kaneko A Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012 [TBL] [Abstract][Full Text] [Related]